{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T21:07:06Z","timestamp":1787778426737,"version":"build-2784847793"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejim.2018.04.019","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T13:23:04Z","timestamp":1524748984000},"page":"3-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Cholecystectomy and risk of metabolic syndrome"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-7376","authenticated-orcid":false,"given":"Agostino","family":"Di Ciaula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Garruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Q.-H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-1471","authenticated-orcid":false,"given":"Piero","family":"Portincasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2018.04.019_bb0005","series-title":"Yamada's Textbook of Gastroenterology","first-page":"1808","article-title":"Gallstones","author":"Portincasa","year":"2015"},{"key":"10.1016\/j.ejim.2018.04.019_bb0010","series-title":"Yamada's Atlas of Gastroenterology","first-page":"335","article-title":"Gallstones","author":"Portincasa","year":"2016"},{"key":"10.1016\/j.ejim.2018.04.019_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejim.2018.04.019_bb0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1586\/17474124.2016.1109445","article-title":"Management of gallstones and its related complications","volume":"10","author":"Portincasa","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5604\/01.3001.0010.5493","article-title":"Bile acid physiology","volume":"16","author":"Di Ciaula","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/labinvest.2017.95","article-title":"Cholecystectomy as a risk factor of metabolic syndrome: from epidemiologic clues to biochemical mechanisms","volume":"98","author":"Chen","year":"2018","journal-title":"Lab Invest"},{"key":"10.1016\/j.ejim.2018.04.019_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/labinvest.2017.129","article-title":"Cholecystectomy: a way forward and back to metabolic syndrome?","volume":"98","author":"Garruti","year":"2018","journal-title":"Lab Invest"},{"key":"10.1016\/j.ejim.2018.04.019_bb0040","series-title":"Consensus worldwide definition of the metabolic syndrome. Brussels","author":"IDF","year":"2006"},{"key":"10.1016\/j.ejim.2018.04.019_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cld.2017.08.010","article-title":"Nonalcoholic fatty liver disease and metabolic syndrome","volume":"22","author":"Kim","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ejim.2018.04.019_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/JHC.S44521","article-title":"A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma","volume":"2","author":"Belghiti","year":"2015","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.ejim.2018.04.019_bb0055","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","article-title":"Prevalence of the metabolic syndrome in individuals with hyperuricemia","volume":"120","author":"Choi","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2018.04.019_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcn\/80.1.1","article-title":"Cholesterol gallstones: a fellow traveler with metabolic syndrome?","volume":"80","author":"Grundy","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejim.2018.04.019_bb0065","series-title":"Colloquium Series on Integrated Systems Physiology: From Molecule to Function","article-title":"The biliary system","volume":"8","author":"Wang","year":"2017"},{"key":"10.1016\/j.ejim.2018.04.019_bb0070","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ejim.2018.04.019_bb0075","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/cphy.c150050","article-title":"Functions of the gallbladder","volume":"6","author":"Housset","year":"2016","journal-title":"Compr Physiol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0080","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/hep.22204","article-title":"Coordinate regulation of gallbladder motor function in the gut-liver axis","volume":"47","author":"Portincasa","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0085","series-title":"Gallbladder and Biliary Tract Diseases","first-page":"39","article-title":"Gallbladder smooth muscle function and its dysfunction in cholesterol gallstone disease","author":"Portincasa","year":"2000"},{"key":"10.1016\/j.ejim.2018.04.019_bb0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2018.04.019_bb0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.steroids.2014.04.016","article-title":"Bile acids are nutrient signaling hormones","volume":"86","author":"Zhou","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.ejim.2018.04.019_bb0100","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Chavez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0105","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1530\/JOE-15-0469","article-title":"The role of bile acids in metabolic regulation","volume":"228","author":"Vitek","year":"2016","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.ejim.2018.04.019_bb0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1084\/jem.20171965","article-title":"Bile acids in glucose metabolism in health and disease","volume":"215","author":"Shapiro","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.ejim.2018.04.019_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mam.2017.03.002","article-title":"Bile acids and their receptors during liver regeneration: \u201cdangerous protectors\u201d","volume":"56","author":"Merlen","year":"2017","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ejim.2018.04.019_bb0120","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/en.2003-1671","article-title":"Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0125","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejim.2018.04.019_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mam.2017.01.006","article-title":"Bile acids and their receptors","volume":"56","author":"Martinot","year":"2017","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ejim.2018.04.019_bb0135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.ejim.2018.04.019_bb0140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1534-5807(02)00187-9","article-title":"Redundant pathways for negative feedback regulation of bile acid production","volume":"2","author":"Wang","year":"2002","journal-title":"Dev. Cell."},{"key":"10.1016\/j.ejim.2018.04.019_bb0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/mp700105z","article-title":"Mini-review: endocrine actions of fibroblast growth factor 19","volume":"5","author":"Jones","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ejim.2018.04.019_bb0150","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s11695-017-2549-1","article-title":"Mechanisms of action of surgical interventions on weight-related diseases: the potential role of bile acids","volume":"27","author":"Mazidi","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/j.ejim.2018.04.019_bb0155","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1074\/jbc.M808818200","article-title":"Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis","volume":"284","author":"Bhatnagar","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejim.2018.04.019_bb0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fphar.2017.00162","article-title":"Targeting bile acid receptors: discovery of a potent and selective Farnesoid X receptor agonist as a new lead in the pharmacological approach to liver diseases","volume":"8","author":"Festa","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0165","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","article-title":"Pleiotropic roles of bile acids in metabolism","volume":"17","author":"de Aguiar Vallim","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.ejim.2018.04.019_bb0170","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.tiv.2012.12.020","article-title":"Bile acids in the colon, from healthy to cytotoxic molecules","volume":"27","author":"Barrasa","year":"2013","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.ejim.2018.04.019_bb0175","first-page":"5118","article-title":"Farnesoid X receptor ligand CDCA suppresses human prostate cancer cells growth by inhibiting lipid metabolism via targeting sterol response element binding protein 1","volume":"8","author":"Liu","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ejim.2018.04.019_bb0180","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/en.2015-1321","article-title":"Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors","volume":"156","author":"Brighton","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.ejim.2018.04.019_bb0190","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clinre.2012.03.008","article-title":"Perspective: TGR5 (Gpbar-1) in liver physiology and disease","volume":"36","author":"Keitel","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0195","doi-asserted-by":"crossref","first-page":"G413","DOI":"10.1152\/ajpgi.00435.2012","article-title":"Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients","volume":"304","author":"Sonne","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2005.11.005","article-title":"GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow","volume":"130","author":"Guan","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0205","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.004","article-title":"The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation","volume":"54","author":"Pols","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1677\/joe.1.06546","article-title":"Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1\/M-Bar) in mice","volume":"191","author":"Maruyama","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0215","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1172\/JCI108705","article-title":"Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity","volume":"59","author":"Shaffer","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2018.04.019_bb0220","series-title":"Motility of the Biliary Tract","author":"Shaffer","year":"1994"},{"key":"10.1016\/j.ejim.2018.04.019_bb0225","series-title":"Physiology of the gastrointestinal tract","first-page":"695","article-title":"Motility of the gallbladder and biliary tree","author":"Ryan","year":"1987"},{"key":"10.1016\/j.ejim.2018.04.019_bb0230","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gut.42.6.830","article-title":"Motilin induces gall bladder emptying and antral contractions in the fasted state in humans","volume":"42","author":"Luiking","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2018.04.019_bb0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2982.2000.00217.x","article-title":"Acute intraduodenal bile salt depletion leads to strong gallbladder contraction, altered antroduodenal motility and high plasma motilin levels in humans","volume":"12","author":"Portincasa","year":"2000","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.ejim.2018.04.019_bb0240","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(06)69044-2","article-title":"Cholesterol gallstone disease","volume":"368","author":"Portincasa","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2018.04.019_bb0245","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/1568008054064850","article-title":"Water transport into bile and role in bile formation","volume":"5","author":"Calamita","year":"2005","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"10.1016\/j.ejim.2018.04.019_bb0250","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.23032","article-title":"The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0255","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejim.2018.04.019_bb0260","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm1501","article-title":"Identification of a hormonal basis for gallbladder filling","volume":"12","author":"Choi","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejim.2018.04.019_bb0265","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1665-2681(19)30766-5","article-title":"Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19","volume":"14","author":"Barrera","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0270","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.24702","article-title":"The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract","volume":"55","author":"Zweers","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ejim.2018.04.019_bb0275","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","article-title":"Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man","volume":"260","author":"Lundasen","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2018.04.019_bb0280","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0016-5085(99)70456-7","article-title":"Prevalence and ethnic differences in gallbladder disease in the United States","volume":"117","author":"Everhart","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0285","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States","volume":"122","author":"Sandler","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0290","doi-asserted-by":"crossref","unstructured":"Di Ciaula A, Wang DQ, Portincasa P. An update on the pathogenesis of cholesterol gallstone disease. Curr. Opin. Gastroenterol. 2017.","DOI":"10.1097\/MOG.0000000000000423"},{"key":"10.1016\/j.ejim.2018.04.019_bb0295","first-page":"298421","article-title":"Current views on genetics and epigenetics of cholesterol gallstone disease","author":"Di Ciaula","year":"2013","journal-title":"Cholesterol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0300","first-page":"641","article-title":"Metabolic and health complications of obesity","volume":"36","author":"Grundy","year":"1990","journal-title":"Dis Mon"},{"key":"10.1016\/j.ejim.2018.04.019_bb0305","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/01.ATV.0000189155.75833.c7","article-title":"Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute","volume":"25","author":"Grundy","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejim.2018.04.019_bb0310","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2018.04.019_bb0315","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2018.04.019_bb0320","series-title":"Gallstones: Recent Advances in Epidemiology, Pathogenesis, Diagnosis and Management","first-page":"357","article-title":"Role of insulin resistance in the formation of cholesterol gallstones","author":"Di Ciaula","year":"2017"},{"key":"10.1016\/j.ejim.2018.04.019_bb0325","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3748\/wjg.v11.i11.1653","article-title":"Metabolic syndrome as a risk factor for gallstone disease","volume":"11","author":"Mendez-Sanchez","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0330","series-title":"Clinical Practice Guideline Panel: Frank Lammert (Chairman)","first-page":"146","article-title":"EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones","volume":"65","author":"Lammert","year":"2016"},{"key":"10.1016\/j.ejim.2018.04.019_bb0335","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1098-3597(05)80066-3","article-title":"A constellation of complications: the metabolic syndrome","volume":"7","author":"Grundy","year":"2005","journal-title":"Clin Cornerstone"},{"key":"10.1016\/j.ejim.2018.04.019_bb0340","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.gtc.2010.02.003","article-title":"Epidemiology of gallstones","volume":"39","author":"Stinton","year":"2010","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.ejim.2018.04.019_bb0345","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ajcn\/80.1.38","article-title":"Prospective study of abdominal adiposity and gallstone disease in US men","volume":"80","author":"Tsai","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejim.2018.04.019_bb0350","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2018.04.019_bb0355","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3346\/jkms.2008.23.4.644","article-title":"Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men","volume":"23","author":"Chang","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ejim.2018.04.019_bb0360","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.3748\/wjg.v18.i31.4215","article-title":"Metabolic syndrome and gallstone disease","volume":"18","author":"Chen","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0365","article-title":"Association of cholecystectomy with metabolic syndrome in a Chinese population","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2018.04.019_bb0370","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1155\/2011\/356761","article-title":"The metabolic syndrome is associated with complicated gallstone disease","volume":"25","author":"Ata","year":"2011","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0375","doi-asserted-by":"crossref","first-page":"409","DOI":"10.9734\/AIR\/2014\/10071","article-title":"Association between air pollutant emissions and type 1 diabetes incidence in European Countries","volume":"2","author":"Di Ciaula","year":"2014","journal-title":"Adv. Res."},{"key":"10.1016\/j.ejim.2018.04.019_bb0380","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ejim.2014.10.012","article-title":"Fat, epigenome and pancreatic diseases. Interplay and common pathways from a toxic and obesogenic environment","volume":"25","author":"Di Ciaula","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2018.04.019_bb0385","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2174\/1389201017666160301103835","article-title":"Nature and nurture in the early-life origins of metabolic syndrome","volume":"17","author":"Gonzalez-Bulnes","year":"2016","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0390","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(05)80324-1","article-title":"Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation","volume":"21","author":"Portincasa","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0395","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2362.2000.00639.x","article-title":"Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones","volume":"30","author":"Portincasa","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2018.04.019_bb0400","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3748\/wjg.v10.i16.2383","article-title":"Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults","volume":"10","author":"Portincasa","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0405","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1007\/s10620-009-1035-6","article-title":"Surgeon volume metrics in laparoscopic cholecystectomy","volume":"55","author":"Csikesz","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.ejim.2018.04.019_bb0410","article-title":"Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis","volume":"18","author":"Keus","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ejim.2018.04.019_bb0415","article-title":"Laparoscopic versus small-incision cholecystectomy for patients with symptomatic cholecystolithiasis","volume":"18","author":"Keus","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2018.04.019_bb0420","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/bjs.9887","article-title":"Prospective multicentre cohort study of patient-reported outcomes after cholecystectomy for uncomplicated symptomatic cholecystolithiasis","volume":"102","author":"Lamberts","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejim.2018.04.019_bb0425","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.mam.2012.03.010","article-title":"Water channel proteins in bile formation and flow in health and disease: when immiscible becomes miscible","volume":"33","author":"Portincasa","year":"2012","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ejim.2018.04.019_bb0430","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0022-2275(20)30276-5","article-title":"Cholecystectomy prevents expansion of the bile acid pool and inhibition of cholesterol 7alpha-hydroxylase in rabbits fed cholesterol","volume":"42","author":"Xu","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2018.04.019_bb0435","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.1840210109","article-title":"Long-term effects of cholecystectomy on bile acid metabolism","volume":"21","author":"Kullak-Ublick","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0440","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1478-3231.2010.02361.x","article-title":"Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice","volume":"31","author":"Amigo","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2018.04.019_bb0445","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1172\/JCI114050","article-title":"Effects of cholecystectomy on the kinetics of primary and secondary bile acids","volume":"83","author":"Berr","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2018.04.019_bb0450","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF01076595","article-title":"Bile acid secretion and biliary bile acid composition altered by cholecystectomy","volume":"18","author":"Malagelada","year":"1973","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.ejim.2018.04.019_bb0455","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/BF01073029","article-title":"Composition of biliary lipids and kinetics of bile acids after cholecystectomy in man","volume":"21","author":"Kimball","year":"1976","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.ejim.2018.04.019_bb0460","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/gut.19.7.640","article-title":"Enterohepatic circulation of bile acids after cholecystectomy","volume":"19","author":"Roda","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2018.04.019_bb0465","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/gast.1996.v111.pm8780565","article-title":"Bowel habit after cholecystectomy: physiological changes and clinical implications","volume":"111","author":"Fort","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0470","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM197312062892302","article-title":"Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy","volume":"289","author":"Almond","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.04.019_bb0475","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/gut.5.6.607","article-title":"Effect of cholecystectomy on the role of the gall bladder in fat absorption","volume":"5","author":"Krondl","year":"1964","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2018.04.019_bb0480","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0016-5085(74)80044-2","article-title":"Increased bacterial degradation of bile acids in cholecystectomized patients","volume":"66","author":"Hepner","year":"1974","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0485","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gut.14.10.753","article-title":"The effect of cholecystectomy on bile salt metabolism","volume":"14","author":"Pomare","year":"1973","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2018.04.019_bb0490","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.02.033","article-title":"Defects in gallbladder emptying and bile acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies","volume":"142","author":"Debray","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0495","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1053\/j.gastro.2012.04.036","article-title":"A cholecystohepatic shunt pathway: does the gallbladder protect the liver?","volume":"142","author":"Boyer","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0500","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/BF01316508","article-title":"Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy","volume":"38","author":"Zuccato","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejim.2018.04.019_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118478","article-title":"Metabolic effects of cholecystectomy: gallbladder ablation increases basal metabolic rate through G-protein coupled bile acid receptor Gpbar1-dependent mechanisms in mice","volume":"10","author":"Cortes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2018.04.019_bb0510","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1665-2681(19)31490-5","article-title":"Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease","volume":"11","author":"Chavez-Tapia","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0515","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/ajg.2013.70","article-title":"Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population","volume":"108","author":"Ruhl","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0520","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.3748\/wjg.v21.i20.6287","article-title":"Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population","volume":"21","author":"Kwak","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0525","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/ajg.2009.737","article-title":"Cholelithiasis, cholecystectomy, and liver disease","volume":"105","author":"Ioannou","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0530","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jhep.2006.01.026","article-title":"Gallbladder disease is associated with insulin resistance in a high risk Hispanic population","volume":"45","author":"Nervi","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0535","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/bmj.289.6455.1350","article-title":"Weight gain after cholecystectomy","volume":"289","author":"Houghton","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ejim.2018.04.019_bb0540","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/2229-516X.212968","article-title":"Pre- and post-operative comparative analysis of serum lipid profile in patients with cholelithiasis","volume":"7","author":"Gill","year":"2017","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"10.1016\/j.ejim.2018.04.019_bb0545","first-page":"377","article-title":"Effect of cholecystectomy on plasma lipid and lipoprotein levels","volume":"42","author":"Juvonen","year":"1995","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0550","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s00268-015-3396-7","article-title":"Cholecystectomy causes ultrasound evidence of increased hepatic steatosis","volume":"40","author":"Yun","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.ejim.2018.04.019_bb0555","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2174\/138161207781039652","article-title":"Non-alcoholic fatty liver disease in the metabolic syndrome","volume":"13","author":"Palasciano","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejim.2018.04.019_bb0560","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.3748\/wjg.v21.i12.3614","article-title":"Cholecystectomy does not significantly increase the risk of fatty liver disease","volume":"21","author":"Wang","year":"2015","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.ejim.2018.04.019_bb0565","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-017-0525-3","article-title":"Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study","volume":"16","author":"Cort\u00e9s","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ejim.2018.04.019_bb0570","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3109\/09637486.2011.644767","article-title":"Measuring the rate of weight gain and the influential role of diet in patients undergoing elective laparoscopic cholecystectomy: a 6-month follow-up study","volume":"63","author":"Yazdankhah Kenary","year":"2012","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.ejim.2018.04.019_bb0575","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02914515","article-title":"Weight gain after laparoscopic cholecystectomy","volume":"173","author":"Ali","year":"2004","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.ejim.2018.04.019_bb0580","first-page":"A10","article-title":"Acute but not chronic cholestyramine (CH) administration profoundly affects gallbladder (GB) and antroduodenal motility","volume":"46","author":"Portincasa","year":"1995","journal-title":"Neth J Med"},{"key":"10.1016\/j.ejim.2018.04.019_bb0585","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0016-5085(92)90113-D","article-title":"Opposite effects of cholestyramine and loxiglumide on gallbladder dynamics in humans","volume":"102","author":"Palasciano","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0590","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/endo.143.5.8850","article-title":"Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity","volume":"143","author":"Tomlinson","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0595","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000282091","article-title":"Bile acids as regulators of hepatic lipid and glucose metabolism","volume":"28","author":"Trauner","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.ejim.2018.04.019_bb0600","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1194\/jlr.R900007-JLR200","article-title":"Bile acids as regulatory molecules","volume":"50","author":"Hylemon","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2018.04.019_bb0605","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ejim.2018.04.019_bb0610","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrendo.2014.60","article-title":"Beyond intestinal soap\u2014bile acids in metabolic control","volume":"10","author":"Kuipers","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2017.07.001","article-title":"Bile acids, roles in integrative physiology and pathophysiology","volume":"56","author":"Volle","year":"2017","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ejim.2018.04.019_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014412","article-title":"The receptor tyrosine kinase FGFR4 negatively regulates NF-kappaB signaling","volume":"5","author":"Drafahl","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2018.04.019_bb0625","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"Holt","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.ejim.2018.04.019_bb0630","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2018.04.019_bb0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067160","article-title":"Association between serum atypical fibroblast growth factors 21 and 19 and pediatric nonalcoholic fatty liver disease","volume":"8","author":"Alisi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2018.04.019_bb0640","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ajg.2013.84","article-title":"Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences?","volume":"108","author":"Nervi","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0645","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/00365521.2014.894119","article-title":"Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?","volume":"49","author":"Ahmed","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0650","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2018.04.019_bb0655","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.04.019_bb0660","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jhep.2013.11.034","article-title":"Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity","volume":"60","author":"Vrieze","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0665","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/1471-2164-14-669","article-title":"Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study","volume":"14","author":"Wu","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ejim.2018.04.019_bb0670","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/1758-2229.12319","article-title":"Interactions between the intestinal microbiota and bile acids in gallstones patients","volume":"7","author":"Keren","year":"2015","journal-title":"Environ Microbiol Rep"},{"key":"10.1016\/j.ejim.2018.04.019_bb0675","doi-asserted-by":"crossref","first-page":"10178","DOI":"10.1073\/pnas.1712837114","article-title":"Gallbladder-derived surfactant protein D regulates gut commensal bacteria for maintaining intestinal homeostasis","volume":"114","author":"Sarashina-Kida","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2018.04.019_bb0680","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/17425255.2014.999664","article-title":"Farnesoid x receptor in human metabolism and disease: the interplay between gene polymorphisms, clinical phenotypes and disease susceptibility","volume":"11","author":"Koutsounas","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0685","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/ijo.2009.152","article-title":"Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study","volume":"33","author":"van den Berg","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ejim.2018.04.019_bb0690","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2013-1177","article-title":"Genetic variation inNR1H4Encoding the bile acid receptor FXR determines fasting glucose and free fatty acid levels in humans","volume":"98","author":"Heni","year":"2013","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.ejim.2018.04.019_bb0695","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1517\/14728222.2013.823403","article-title":"Pregnane X receptor polymorphisms associated with human diseases","volume":"17","author":"Kotta-Loizou","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.ejim.2018.04.019_bb0700","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.soard.2013.12.019","article-title":"Altered promoter methylation of PDK4, IL1 B, IL6, and TNF after roux-en Y gastric bypass","volume":"10","author":"Kirchner","year":"2014","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.ejim.2018.04.019_bb0705","doi-asserted-by":"crossref","DOI":"10.2174\/0929867324666170518095736","article-title":"Diet and contaminants: driving the rise to obesity epidemics?","volume":"24","author":"Di Ciaula","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ejim.2018.04.019_bb0710","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/gut.19.1.32","article-title":"Physiological factors influencing serum bile acid levels","volume":"19","author":"Ponz De Leon","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2018.04.019_bb0715","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gut.19.11.1006","article-title":"Diurnal serum levels of primary conjugated bile acids. Assessment by specific radioimmunoassays for conjugates of cholic and chenodeoxycholic acid","volume":"19","author":"Schalm","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2018.04.019_bb0720","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM197410032911401","article-title":"Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption","volume":"291","author":"LaRusso","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.04.019_bb0725","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mam.2017.06.002","article-title":"Interactions between gut bacteria and bile in health and disease","volume":"56","author":"Long","year":"2017","journal-title":"Mol Aspects Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518301730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518301730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T02:29:45Z","timestamp":1661048985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620518301730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":145,"alternative-id":["S0953620518301730"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2018.04.019","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholecystectomy and risk of metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2018.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}